SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Ask Michael Burke
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Knighty Tin who wrote (26005)2/13/1998 4:43:00 PM
From: geewiz  Read Replies (1) of 132070
 
Mike,

Which bio-techs have the best management? By best management I mean which companies are best able to usher their product through the FDA maze in a timely and cost-efficient manner. I remember the fiasco last year when the dim-wits at Cephelon brought their patients with Lou Gehrigs'(?) to testify on the drugs' benefits! They were really cocky about it boasting that they bought a bunch of calls on their equity. If I remember, you were buying puts hey?

Is there an opportunity in drug service testing companies? PPDI or CRLS?? As genetic drugs become more wide spread these companies should benefit from the quantity of testing and not have the exposure of a failure.

Do you have an opinion on Michael Gianturco, the bio-tec columnist in Forbes?

best, art
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News